MeSH term
Frequency | Condition_Probility | Blotting, Western | 5 | 0.0 |
Cell Line | 50 | 0.0 |
Electrophoresis | 4 | 1.0 |
Humans | 164 | 0.0 |
Research Support, Non-U.S. Gov't | 107 | 0.0 |
Retinoid X Receptors | 21 | 7.0 |
Transfection | 52 | 0.0 |
Cell Division | 2 | 0.0 |
Adult | 11 | 0.0 |
Aged | 2 | 0.0 |
Female | 16 | 0.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Male | 19 | 0.0 |
Receptors, Thyroid Hormone/*metabolism | 10 | 27.0 |
Animals | 93 | 0.0 |
Base Sequence | 100 | 0.0 |
Genes, Reporter | 9 | 0.0 |
Hela Cells | 14 | 0.0 |
Luciferases/genetics | 5 | 1.0 |
Molecular Sequence Data | 95 | 0.0 |
Rats | 43 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Response Elements | 5 | 2.0 |
*Trans-Activation (Genetics) | 6 | 0.0 |
Triiodothyronine/*metabolism/pharmacology | 2 | 33.0 |
Genetic Vectors | 9 | 0.0 |
Mice | 28 | 0.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
Tumor Cells, Cultured | 25 | 0.0 |
Cells, Cultured | 23 | 0.0 |
DNA-Binding Proteins/*metabolism | 14 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Epithelial Cells/drug effects/metabolism | 2 | 2.0 |
Kinetics | 9 | 0.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 69 | 0.0 |
Signal Transduction | 9 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 16 | 0.0 |
DNA/genetics/metabolism | 4 | 1.0 |
Macromolecular Substances | 7 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 15 | 0.0 |
Proto-Oncogene Proteins c-fos/genetics/*metabolism | 2 | 8.0 |
Response Elements/*genetics | 2 | 3.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Blotting, Northern | 10 | 0.0 |
Promoter Regions (Genetics) | 28 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Triiodothyronine/*pharmacology | 11 | 22.0 |
COS Cells | 6 | 0.0 |
DNA/metabolism | 12 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Mutation/*physiology | 2 | 1.0 |
Triiodothyronine/physiology | 4 | 66.0 |
Analysis of Variance | 2 | 0.0 |
Binding, Competitive | 11 | 0.0 |
Mutation | 15 | 0.0 |
Nuclear Proteins/metabolism | 6 | 0.0 |
Receptors, Retinoic Acid/metabolism | 6 | 6.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Transcription Factors/metabolism | 7 | 0.0 |
Cercopithecus aethiops | 8 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
Receptors, Thyroid Hormone/chemistry/*genetics/metabolism | 3 | 100.0 |
Structure-Activity Relationship | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 5 | 0.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
*Transcription, Genetic | 12 | 0.0 |
Virus Latency | 2 | 3.0 |
Amino Acid Sequence | 21 | 0.0 |
Animals, Newborn | 3 | 0.0 |
Cell Nucleus/metabolism | 6 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 5 | 1.0 |
*Introns | 2 | 0.0 |
Liver/enzymology | 2 | 0.0 |
Mutagenesis, Site-Directed | 9 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
*Promoter Regions (Genetics) | 21 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Sequence Analysis, DNA | 6 | 0.0 |
Thyroid Hormones/*metabolism | 2 | 6.0 |
Triiodothyronine/metabolism | 8 | 22.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
Isoenzymes/*metabolism | 2 | 0.0 |
Receptors, Estrogen/genetics/physiology | 2 | 28.0 |
Receptors, Retinoic Acid/genetics/physiology | 2 | 18.0 |
Recombinant Fusion Proteins | 4 | 1.0 |
Thymidine Kinase/genetics | 4 | 4.0 |
*Transcription, Genetic/drug effects | 3 | 2.0 |
Triiodothyronine/pharmacology | 5 | 10.0 |
DNA Primers | 6 | 0.0 |
Gene Expression Regulation/*drug effects | 13 | 2.0 |
Tetracycline/*pharmacology | 2 | 11.0 |
Chickens | 7 | 0.0 |
DNA/*metabolism | 11 | 2.0 |
Dimerization | 7 | 0.0 |
Muramidase/genetics | 2 | 20.0 |
Receptors, Thyroid Hormone/chemistry/*genetics/*metabolism | 2 | 100.0 |
Reference Values | 2 | 0.0 |
Comparative Study | 21 | 0.0 |
Growth Hormone/*genetics | 3 | 8.0 |
DNA, Complementary/genetics | 4 | 0.0 |
In Vitro | 4 | 0.0 |
Ligands | 9 | 0.0 |
Models, Biological | 3 | 0.0 |
Receptors, Thyroid Hormone/chemistry/genetics/*metabolism | 3 | 75.0 |
Trans-Activation (Genetics) | 11 | 0.0 |
Rabbits | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Transcription Factors/*metabolism | 9 | 0.0 |
Adolescent | 2 | 0.0 |
Exercise Test | 2 | 0.0 |
Sweating/physiology | 2 | 50.0 |
Blotting, Southern | 5 | 0.0 |
Restriction Mapping | 11 | 0.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 4 | 2.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid | 10 | 1.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 15 | 4.0 |
Transcription, Genetic | 25 | 0.0 |
Binding Sites | 24 | 0.0 |
Mutagenesis | 3 | 0.0 |
Rats, Sprague-Dawley | 4 | 0.0 |
Receptors, Thyroid Hormone/genetics/*metabolism | 5 | 22.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
*DNA-Binding Proteins | 7 | 0.0 |
Exons | 4 | 0.0 |
Introns | 4 | 0.0 |
*Transcription Factors | 10 | 0.0 |
Biological Markers | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
DNA | 8 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 2 | 1.0 |
*Gene Expression Regulation | 11 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 4 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Transcription Factor AP-1/metabolism | 3 | 1.0 |
*Gene Expression Regulation, Viral | 5 | 1.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Protein Conformation | 4 | 0.0 |
*Genes, jun | 3 | 6.0 |
Recombinant Fusion Proteins/biosynthesis | 6 | 1.0 |
Chloramphenicol O-Acetyltransferase/genetics | 7 | 2.0 |
Receptors, Retinoic Acid/genetics | 2 | 2.0 |
Transcription Factors/genetics | 3 | 0.0 |
Transcription, Genetic/drug effects | 10 | 1.0 |
Triiodothyronine/pharmacology/physiology | 2 | 66.0 |
Alkaline Phosphatase/*genetics/metabolism | 2 | 40.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Protein Isoforms/genetics/metabolism | 2 | 1.0 |
Thyroid Hormones/*pharmacology | 6 | 35.0 |
Cell Line, Transformed | 2 | 0.0 |
Transcription, Genetic/*drug effects | 6 | 1.0 |
Up-Regulation | 2 | 0.0 |
3T3 Cells | 5 | 0.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 5 | 3.0 |
Deoxyribonuclease I | 2 | 1.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Protein Biosynthesis | 7 | 0.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
*Regulatory Sequences, Nucleic Acid | 12 | 3.0 |
Promoter Regions (Genetics)/genetics | 4 | 0.0 |
Enzyme Activation | 8 | 0.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Proto-Oncogene Proteins c-jun/metabolism | 5 | 3.0 |
Mitogen-Activated Protein Kinase 12 | 2 | 28.0 |
*Signal Transduction | 4 | 0.0 |
Iodide Peroxidase/*genetics | 2 | 4.0 |
Receptors, Thyroid Hormone/metabolism | 4 | 11.0 |
Repetitive Sequences, Nucleic Acid | 11 | 1.0 |
Transcription Factor, Sp1/metabolism | 4 | 1.0 |
Tretinoin/pharmacology | 3 | 0.0 |
Antibody Specificity | 2 | 0.0 |
HIV Long Terminal Repeat/*genetics | 2 | 2.0 |
Enzyme Induction/drug effects | 2 | 0.0 |
Umbilical Veins | 2 | 0.0 |
DNA, Neoplasm/metabolism | 3 | 2.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Proto-Oncogene Proteins c-fos/metabolism | 2 | 1.0 |
Regulatory Sequences, Nucleic Acid/*genetics | 2 | 2.0 |
Transcription Factor AP-1/*metabolism | 6 | 3.0 |
Gene Expression | 8 | 0.0 |
Monocyte Chemoattractant Protein-1/*genetics | 2 | 10.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 3 | 1.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 2 | 2.0 |
Conserved Sequence | 4 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Receptors, Thyroid Hormone/*genetics | 6 | 20.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Cloning, Molecular | 17 | 0.0 |
Point Mutation | 5 | 0.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 6 | 0.0 |
Proto-Oncogene Proteins c-jun/*genetics/metabolism | 2 | 22.0 |
Sheep | 2 | 0.0 |
Phosphorylation | 5 | 0.0 |
Protein Kinases/*metabolism | 3 | 0.0 |
Thyroid Hormones/genetics/*metabolism | 2 | 100.0 |
Cyclic AMP/pharmacology | 2 | 1.0 |
*Enhancer Elements (Genetics) | 5 | 1.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
Genes, Structural | 3 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
Culture Media | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Enhancer Elements (Genetics)/*genetics | 2 | 2.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Trans-Activators/*genetics | 2 | 0.0 |
8-Bromo Cyclic Adenosine Monophosphate/pharmacology | 2 | 2.0 |
Forskolin/pharmacology | 3 | 0.0 |
Protein Kinase C/metabolism | 6 | 1.0 |
Collagenases/genetics | 2 | 10.0 |
Protein Kinase C/*metabolism | 4 | 1.0 |
Plasmids | 10 | 0.0 |
Consensus Sequence | 4 | 0.0 |
Drug Resistance | 2 | 0.0 |
Cattle | 4 | 0.0 |
*Endopeptidases | 2 | 6.0 |
*Oncogene Proteins | 2 | 3.0 |
Cell Differentiation | 2 | 0.0 |
Oligonucleotide Probes | 3 | 0.0 |
Endothelium, Vascular/drug effects/*metabolism | 2 | 2.0 |
Oligodeoxyribonucleotides | 4 | 0.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
*Trans-Activation (Genetics)/drug effects | 2 | 4.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase | 2 | 1.0 |
Cell Compartmentation | 2 | 0.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 2 | 2.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Receptors, Platelet-Derived Growth Factor/*physiology | 2 | 50.0 |
Thyroid Hormones/pharmacology | 2 | 22.0 |
Protein Hybridization | 2 | 3.0 |
Organ Specificity | 3 | 0.0 |
Receptors, Thyroid Hormone/*physiology | 3 | 42.0 |
Triiodothyronine/metabolism/pharmacology | 2 | 50.0 |
Antioxidants/*pharmacology | 2 | 1.0 |
Benzoflavones/pharmacology | 2 | 4.0 |
DNA Mutational Analysis | 2 | 0.0 |
Enhancer Elements (Genetics) | 5 | 1.0 |
Enzyme Induction | 3 | 0.0 |
Recombinant Proteins/biosynthesis/metabolism | 2 | 1.0 |
beta-Naphthoflavone | 2 | 11.0 |
Genomic Library | 3 | 0.0 |
Triiodothyronine/*metabolism | 2 | 20.0 |
*Gene Expression | 3 | 0.0 |
Genes, Regulator | 2 | 1.0 |
*Heat | 4 | 3.0 |
Isoquinolines/pharmacology | 2 | 1.0 |
Phorbol Esters/pharmacology | 2 | 1.0 |
Glutathione Transferase/*genetics | 2 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
*Oncogenes | 3 | 0.0 |
Genes, Viral | 2 | 0.0 |
Human T-lymphotropic virus 1/*genetics | 2 | 3.0 |
Escherichia coli/genetics | 2 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Liver/*enzymology | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis/metabolism | 3 | 11.0 |
English Abstract | 3 | 0.0 |
*Receptors, Retinoic Acid | 6 | 42.0 |
Calcium/physiology | 2 | 0.0 |
Gene Expression/*drug effects | 2 | 0.0 |
Homeostasis | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 2 | 1.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Alkaloids/pharmacology | 2 | 1.0 |
Staurosporine | 2 | 2.0 |
Body Temperature | 5 | 5.0 |
Rectum | 2 | 25.0 |
Skin Temperature | 4 | 11.0 |
Time Factors | 3 | 0.0 |
Cholesterol 7-alpha-Hydroxylase/*genetics | 2 | 10.0 |
Genes, jun | 3 | 3.0 |
Receptors, Retinoic Acid | 7 | 12.0 |
Actins/*genetics | 2 | 3.0 |
Bone and Bones/*chemistry | 2 | 15.0 |
Triiodothyronine/*physiology | 4 | 40.0 |
Receptors, Thyroid Hormone/physiology | 2 | 25.0 |
Tretinoin/metabolism | 2 | 5.0 |
Phenotype | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 3 | 2.0 |
Proto-Oncogene Proteins c-fos/genetics/metabolism | 2 | 7.0 |
Protein Kinase C/physiology | 2 | 1.0 |
Proto-Oncogenes | 2 | 1.0 |
Pituitary Neoplasms/metabolism | 2 | 12.0 |
Gene Library | 3 | 0.0 |
Cations/metabolism | 2 | 9.0 |
Cell Cycle | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Histones/*genetics/metabolism | 2 | 28.0 |
Muscles/physiology | 2 | 15.0 |
Calcimycin/pharmacology | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
Drug Synergism | 3 | 0.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
Tumor Stem Cells | 2 | 12.0 |
Chromosome Deletion | 3 | 0.0 |
*Genes, Structural/drug effects | 2 | 33.0 |
*Cell Differentiation | 2 | 0.0 |
Receptors, Estrogen/*genetics | 2 | 2.0 |
Proto-Oncogene Proteins c-fos | 4 | 7.0 |
Proto-Oncogene Proteins c-jun | 4 | 8.0 |
*Genes, Structural | 2 | 0.0 |
DNA/genetics | 2 | 0.0 |
Hela Cells/metabolism | 2 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
*Proto-Oncogenes | 2 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
*Body Temperature Regulation | 4 | 14.0 |
*Exertion | 2 | 1.0 |
Oxygen Consumption | 4 | 1.0 |
Sweating | 2 | 22.0 |
Electrophoretic Mobility Shift Assay | 4 | 0.0 |
*Cold | 2 | 3.0 |
